Search | WHO COVID-19 Research Database

WHO COVID-19 Research Database

News/Update/Help

Advanced Search

The WHO Covid-19 Research Database is a resource created in response to the Public Health Emergency of International Concern (PHEIC). Its content remains searchable and spans the time period March 2020 to June 2023. Since June 2023, manual updates to the database have been discontinued.

Show: 20 | 50 | 100

Results 1 - 11 de 11

Filter

Inhalation Vaccine Development

Challener, C. A..

Pharmaceutical Technology ; 47(1):26-29 and 35, 2023.

Article in English | EMBASE | ID: covidwho-2293103

Focus on Fill and Finish

Challener, C. A..

BioPharm International ; 35(10):10-15, 2022.

Article in English | EMBASE | ID: covidwho-2207457

Excipients for High-Concentration Biologics

Challener, C. A..

BioPharm Int. ; 35:17-37, 2022.

Article in English | EMBASE | ID: covidwho-2003051

Analysis of mRNA Therapeutics and Vaccines

Challener, C. A..

BioPharm Int. ; 35:10-15, 2022.

Article in English | EMBASE | ID: covidwho-1995149

Subunit vaccines suited for the fight against covid-19

Challener, C. A..

Pharmaceutical Technology ; 45(7):26-29, 2021.

Article in English | EMBASE | ID: covidwho-1525082

Can vaccine development be safely accelerated? Biopharma companies responding to the COVID-19 outbreak think accelerating the development of vaccines is safe

Challener, C. A..

Embase; 2020.

Non-conventional in English | EMBASE | ID: grc-750731

Plasma-based antibody therapies battle against COVID-19

Challener, C. A..

Embase; 2020.

Non-conventional in English | EMBASE | ID: grc-750730

Exploring the therapeutic value of blood components

Challener, C. A..

Pharmaceutical Technology ; 45(2):20-23, 2021.

Article in English | EMBASE | ID: covidwho-1145825

Tracking api quality during a pandemic

Challener, C. A..

Pharmaceutical Technology ; 44(9):22-27, 2020.

Article in English | EMBASE | ID: covidwho-762508

10.

Can vaccine development be safely accelerated? Biopharma companies responding to the COVID-19 outbreak think accelerating the development of vaccines is safe

Challener, C. A..

Embase; 2020.

Non-conventional in English | EMBASE | ID: covidwho-666835

11.

Plasma-based antibody therapies battle against COVID-19

Challener, C. A..

Embase; 2020.

Non-conventional in English | EMBASE | ID: covidwho-666834

See more details

SEND TO:

Export

RSS

XML

SEND TO:

SELECTION OF CITATIONS

SEARCH DETAIL